Pharmaceutical Associates Inc. has voluntarily recalled 6,288 bottles of Nystatin Oral Suspension (100,000 units per mL), a prescription medication used to treat fungal infections. Testing revealed that the medication was subpotent, meaning it did not meet the required strength specifications during a 12-month quality check. If the medication is not at full strength, it may not effectively treat the infection as intended. Consumers should contact their healthcare provider or pharmacist regarding their treatment and return any remaining product to the place of purchase for a refund.
The medication was found to be 'out of specification' for potency, which means the drug may not have enough active ingredient to effectively treat fungal infections. This could lead to a delay in recovery or the worsening of the patient's condition due to inadequate treatment.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.